Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-10 @ 2:21 PM
Study NCT ID:
NCT00138151
Status:
TERMINATED
Last Update Posted:
2013-11-20
First Post:
2005-08-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000433516
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |